| Incretin therapy for type 2 diabetes mellitus. | |
| | |
MedLine Citation:
|
PMID: 20978879 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
In addition to progressive pancreatic β-cell failure resulting in impaired insulin secretion, and increased insulin resistance in muscle and liver, incretin hormone-related abnormalities have been identified as key underlying defects in patients with type 2 diabetes mellitus. Treatment goals for patients with type 2 diabetes should be aligned with the basic defects of the disease. Many of the available antidiabetes agents correct hyperglycemia but do not impact other cardiovascular risk factors, and may actually aggravate some. This paper reviews the role of defects in the incretin system in the pathophysiology of type 2 diabetes, and discusses recent advances in the use of incretinbased agents that target the fundamental disease mechanisms of type 2 diabetes. The incretinbased agents reduce hyperglycemia and provide beneficial effects on surrogate markers of cardiovascular risk, including weight gain, elevated blood pressure, and dyslipidemia. |
| | |
Authors:
|
David C Klonoff |
Related Documents
:
|
19643439 - Metabolic abnormalities and cardiovascular risk factors in children with myositis. 17320999 - Renin-angiotensin-system blockade in the prevention of diabetes. 7986309 - The epidemiology of coronary heart disease in glucose-intolerant and diabetic subjects. 12600909 - Role of risk factors in the modulation of tissue factor activity and blood thrombogenic... 19279369 - Markers of fetal onset adult diseases. 8299479 - Hyperinsulinemia--how innocent a bystander? 17715829 - Thailand diabetes registry project: type of diabetes, glycemic control and prevalence o... 20064599 - Prevention of type 2 diabetes induced by high fat diet in the c57bl/6j mouse by two med... 16735969 - Kearns sayre syndrome: an unusual form of mitochondrial diabetes. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-10-20 |
Journal Detail:
|
Title: Advances in therapy Volume: 27 ISSN: 1865-8652 ISO Abbreviation: Adv Ther Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8611864 Medline TA: Adv Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 881-94 Citation Subset: T |
Affiliation:
|
Diabetes Research Institute, Mills-Peninsula Health Services, San Mateo, CA 94401, USA. dklonoff@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Structure-respiration function relationships before and after surgical treatment of early-onset scol...
Next Document: Triple sugar screen breath hydrogen test for sugar intolerance in children with functional abdominal...